Revelation Biosciences, Inc. · NASDAQ:REVB

Zygmont Chester Stanley III had 13,285 Revelation Biosciences, Inc. shares withheld for tax (Form 4)

Traded Apr 30, 2026 · Filed May 1, 2026

On Apr 30, 2026, Zygmont Chester Stanley III (Chief Financial Officer) had 13,285 Revelation Biosciences, Inc. shares withheld for tax at US$1.10 for US$14,614, leaving 92,063 shares. Filed May 1, 2026 (Form 4).

Withheld for tax
13,285 shares
Price
US$1.10
Value
US$14,614
Holding after
92,063 shares (held indirectly)
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockShares withheld for tax13,285US$1.1092,063Indirect

Source

View original at SEC

Related